Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Amalgam Rx logo — Enabling better healthcare decisions. In the provider workfl...

Amalgam Rx

Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives.

Founded 2016 United States Wilmington, United States 56 employees Series B Total: $18.59M Biotechnology, Health Care +4

General Information

Company Name Amalgam Rx
Founded Year 2016
Location United States Wilmington, United States +1
Founders / Decision Makers
Team member
Employees 56
Industries Biotechnology, Health Care, Information Technology +3
Funding Stage Series B
Social

Get notified when Amalgam Rx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Amalgam Rx

Amalgam Rx is a US-based startup founded in 2016, which operates within the Biotechnology, Health Care, and Information Technology industries. The company's slogan, "Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives," encapsulates its mission to facilitate optimal decision-making for both healthcare providers and patients. Amalgam Rx achieves this through its suite of EHR Solutions and a modular SaMD platform, catering to leading life sciences companies, health plans, and provider organizations. Notably, its algorithms and applications currently support nearly 10 million patients across 4 continents, with a track record of aiding providers in over 50 million decisions. The most recent milestone for Amalgam Rx is the Series B investment it secured on 05 October 2023, with CVS Health as the investor. This investment attests to the confidence of a major industry player in Amalgam Rx's potential and innovative approach to improving healthcare through advanced technology and data-driven solutions. In conclusion, with its regulated digital products, EHR solutions, and a wealth of real-world evidence (10 billion RWE data points), Amalgam Rx demonstrates its commitment to engaging patients and providers, ultimately contributing to enhanced healthcare decision-making globally. For more details, interested parties can visit amalgamrx.com.

Taxonomy: Healthcare decision-making, EHR Solutions, SaMD platform, Life sciences companies, Health plans, Provider organizations, Regulated digital products, RWE data points, Patient engagement, Provider workflow optimization

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
05 Oct 2023
Series A •••••• 1
Investor
03 Jan 2023
Seed Round •••••• 1
Investor
16 Jun 2017

Amalgam Rx Alternatives & Competitors

Amalgam Rx vs
Phynd Technologies
Phynd Technologies United States

Enterprise Provider Data Management at Scale

Series B
7 employees
Data Analytics, Enterprise Software
Compare Amalgam Rx vs Phynd Technologies
Amalgam Rx vs
Vim
Vim United States

Vim is a point-of-care connection platform that connects data to enhanced workflows directly in prov...

Series B
275 employees
Health Care, Internet
Compare Amalgam Rx vs Vim
Amalgam Rx vs
Affirm Health
Affirm Health United States

Empowering Providers to Simplify Advance Care Planning

Seed
14 employees
Health Care, Pharmaceutical
Compare Amalgam Rx vs Affirm Health

FAQ About Amalgam Rx

Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives.
Amalgam Rx was founded in 2016.
Amalgam Rx is headquartered in Wilmington, United States.
Amalgam Rx operates in the following industries: Biotechnology, Health Care, Information Technology, Life Sciences, Medical Devices, CRM and Sales.
Amalgam Rx has approximately 56 employees.
Amalgam Rx has completed 3 funding rounds, raising a total of $18.59M. The latest funding stage is Series B.
Top alternatives and competitors to Amalgam Rx include Phynd Technologies, Vim, Affirm Health, Whitecoat, Updox by EverHealth. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amalgam Rx and Phynd Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Amalgam Rx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy